NCT00648531View on ClinicalTrials.gov

Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Healthy
Interventions
DRUG

Balsalazide Disodium Capsules 750 mg

3x750mg, single dose fasting

DRUG

Colazal® Capsules 750 mg

3x750mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648531 - Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg | Biotech Hunter | Biotech Hunter